For almost three decades ambroxol has been used in the therapy of airway diseases. In
2002, ambroxol lozenges were marketed for the treatment of sore throat making use of its …

Ambroxol for women at risk of preterm birth for preventing neonatal respiratory distress
syndrome - Gonzalez Garay, AG - 2014 | Cochrane Library Skip to Content Cookies Our site …

Neuropathic pain affects many patients, and treatment today is far from being perfect. Nav1.
8 Na+ channels, which are expressed by small fibre sensory neurons, are promising targets …

Objective: Our purpose was to evaluate the efficacy and safety of ambroxol for the prenatal
prophylaxis of infant respiratory distress syndrome (IRDS). Study Design: This was a …

Background Neuropathic pain is difficult to treat, and the available options are often
inadequate. The expectorant ambroxol also acts as a strong local anaesthetic and blocks …

Objective To evaluate the efficacy and safety of antenatal ambroxol as a preventive
therapeutic of respiratory distress syndrome (RDS) in preterm infants. Methods Randomized …

Хронические воспалительные заболевания нижних дыхательных путей, такие как
хронический бронхит, хроническая обструктивная болезнь легких, бронхоэктатическая …

Several studies have demonstrated that ambroxol stimulates surfactant synthesis and has
antioxidative and antiinflammatory effects. We investigated the effect of ambroxol on lung …

Fibromyalgia appears to present in subgroups with regard to biological pain induction, with
primarily inflammatory, neuropathic/neurodegenerative, sympathetic, oxidative, nitrosative …